CVS raises 2026 EPS guidance floor to $6.98 after revenue reaches $108.4B

CVS reported third-quarter revenue of $108.4 billion, up 5.4% from a year earlier, alongside GAAP diluted EPS of $1.68 and adjusted EPS of $2.09. Cash flow from operations reached $15.3 billion year to date, and the company raised its full-year 2026 GAAP diluted EPS guidance to at least $6.98.

The results follow CVS’s 2025 full-year revenue of $402.1 billion and diluted EPS of $1.39. The latest quarter therefore adds a stronger current-period earnings and cash-flow reference point to a business operating across healthcare services and insurance.

The revenue figure is the direct top-line link to CVS, while adjusted EPS and operating cash flow provide separate measures of quarterly profitability and liquidity. The revised full-year EPS floor is the forward metric that connects the third-quarter performance to the rest of 2026.

The guidance increase does not by itself establish how much of the change reflects underlying operating improvement versus assumptions for the remainder of the year. The difference between GAAP EPS of $1.68 and adjusted EPS of $2.09 also leaves the quality and composition of earnings relevant to the next update.

The next test is CVS’s fourth-quarter and full-year 2026 results, particularly reported GAAP EPS, operating cash flow and whether full-year performance clears the new guidance floor.